Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Reported holdings as of Q2 2026, from 7 quarterly filings.
This filer last reported in Q2 2026; the most recent quarter on file across all filers is Q3 2026. Firms that restructure stop filing under one CIK and start under another, so a successor entity may hold these positions now under a similar name.
Holdings
Download these holdings as CSV
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| VANECK ETF TRUST CALL | SMH | $52.5M | options only | +3.94pp | 2q | OPTIONS | |
| CITIGROUP INC | C | $32.9M | 235,033 | - | new | NEW | |
| GOLDMAN SACHS GROUP INC | GS | $31.3M | 30,971 | - | new | NEW | |
| STATE STR SPDR S&P 500 ETF T CALL | SPY | $29.9M | options only | +6.27pp | 2q | OPTIONS | |
| GLOBAL PMTS INC | GPN | $27.9M | 384,114 | - | new | NEW | |
| NORFOLK SOUTHN CORP | NSC | $25.6M | 81,332 | - | new | NEW | |
| AMERICAN ELEC PWR CO INC | AEP | $25.4M | 185,962 | - | new | NEW | |
| NVIDIA CORPORATION | NVDA | $25.1M | 125,539 | - | new | NEW | |
| EXXON MOBIL CORP | XOMXXXX | $24.5M | 179,273 | - | new | NEW | |
| ISHARES INC PUT | EWY | $17.3M | options only | - | new | OPTIONS | |
| ISHARES INC PUT | EWT | $13.4M | 11,100 | +2.12pp | 2q | -11.2%-$1.7M | |
| ALPHABET INC | GOOGL | $12.3M | 34,557 | -5.26pp | 3q | +11.0%+$1.2M | |
| MICRON TECHNOLOGY INC | MU | $7.5M | 6,519 | - | new | NEW | |
| ISHARES TR CALL | IGV | $7.2M | options only | -14.84pp | 2q | OPTIONS | |
| INTEL CORP | INTC | $4.7M | 33,371 | - | new | NEW | |
| SANDISK CORP | SNDK | $4.6M | 2,008 | - | new | NEW | |
| ARGENX SE | ARGX | $4.1M | 4,392 | - | new | NEW | |
| INFOSYS LTD | INFY | $3.9M | 367,077 | - | new | NEW | |
| CATERPILLAR INC | CAT | $3.8M | 3,539 | - | new | NEW | |
| AXSOME THERAPEUTICS INC | AXSM | $3.4M | 13,831 | -1.73pp | 3q | -15.7%-$629.1K | |
| INSMED INC | INSM | $3.2M | 30,170 | -0.32pp | 3q | +329.9%+$2.5M | |
| UNITEDHEALTH GROUP INC | UNH | $3.2M | 7,657 | -0.56pp | 2q | +46.8%+$1.0M | |
| BRUKER CORP | BRKR | $3.2M | 52,780 | - | new | NEW | |
| MADRIGAL PHARMACEUTICALS INC | MDGL | $3.1M | 5,865 | +0.13pp | 4q | +392.0%+$2.5M | |
| TRAVERE THERAPEUTICS INC | TVTX | $3.1M | 55,112 | - | new | NEW | |
| HUMANA INC | HUM | $3.1M | 7,839 | - | new | NEW | |
| ELI LILLY & CO | LLY | $3.1M | 2,548 | +0.30pp | 3q | +476.5%+$2.5M | |
| REVVITY INC | RVTY | $3.0M | 27,316 | - | new | NEW | |
| PTC THERAPEUTICS INC | PTCT | $3.0M | 36,873 | -1.75pp | 4q | -7.1%-$230.7K | |
| ABBVIE INC | ABBV | $3.0M | 11,928 | - | new | NEW | |
| CHEMED CORP NEW | CHE | $3.0M | 6,365 | - | new | NEW | |
| ISHARES TR | SOXX | $2.9M | 4,590 | - | new | NEW | |
| AGILENT TECHNOLOGIES INC | A | $2.9M | 21,826 | - | new | NEW | |
| NEUROCRINE BIOSCIENCES INC | NBIX | $2.8M | 16,490 | -1.92pp | 3q | -23.5%-$853.8K | |
| TEVA PHARMACEUTICAL INDS LTD | TEVA | $2.8M | 81,993 | -0.09pp | 3q | +217.7%+$1.9M | |
| ASTERA LABS INC | ALAB | $2.6M | 5,293 | - | new | NEW | |
| COOPER COS INC | COO | $2.5M | 34,743 | +0.17pp | 3q | +489.3%+$2.1M | |
| TWIST BIOSCIENCE CORP | TWST | $2.1M | 20,287 | -0.11pp | 3q | +50.5%+$700.7K | |
| QUALCOMM INC | QCOM | $2.1M | 11,141 | - | new | NEW | |
| ACADIA HEALTHCARE COMPANY IN | ACHC | $2.0M | 66,843 | - | new | NEW | |
| DAVITA INC | DVA | $1.8M | 8,046 | - | new | NEW | |
| ALNYLAM PHARMACEUTICALS INC | ALNY | $1.7M | 5,588 | - | new | NEW | |
| CONCENTRA GROUP HOLDINGS PAR | CON | $1.6M | 52,747 | - | new | NEW | |
| BIOMARIN PHARMACEUTICAL INC | BMRN | $1.5M | 27,041 | -2.11pp | 2q | -44.5%-$1.2M | |
| BIOGEN INC | BIIB | $1.5M | 6,838 | -0.44pp | 3q | +45.3%+$460.6K | |
| OSCAR HEALTH INC | OSCR | $1.5M | 51,105 | - | new | NEW | |
| LAM RESEARCH CORP | LRCX | $1.4M | 3,230 | - | new | NEW | |
| SELECT SECTOR SPDR TR | XLV | $1.4M | 8,600 | - | new | NEW | |
| AVANTOR INC | AVTR | $1.3M | 131,088 | - | new | NEW | |
| RAMBUS INC DEL | RMBS | $1.3M | 9,559 | - | new | NEW | |
| REVOLUTION MEDICINES INC | RVMD | $1.1M | 6,100 | -0.44pp | 4q | -23.5%-$350.4K | |
| MODERNA INC | MRNA | $1.0M | 14,841 | -0.55pp | 2q | -13.2%-$158.0K | |
| BRIDGEBIO PHARMA INC | BBIO | $1.0M | 13,454 | -0.16pp | 3q | +132.6%+$571.2K | |
| IONIS PHARMACEUTICALS INC | IONS | $978.3K | 12,338 | -2.39pp | 4q | -68.4%-$2.1M | |
| SELECT SECTOR SPDR TR | XLU | $943.1K | 20,800 | -0.46pp | 4q | +26.8%+$199.5K | |
| INVESCO EXCH TRADED FD TR II | QQQM | $939.2K | 3,100 | - | new | NEW | |
| SELECT SECTOR SPDR TR | XLRE | $880.6K | 20,000 | - | new | NEW | |
| PRAXIS PRECISION MEDICINES I | PRAX | $823.9K | 2,461 | -0.92pp | 3q | -36.2%-$466.7K | |
| NATERA INC | NTRA | $763.9K | 2,814 | -0.36pp | 2q | -5.3%-$42.3K | |
| CYTOKINETICS INC | CYTK | $752.7K | 8,836 | -0.27pp | 3q | +19.6%+$123.4K | |
| ISHARES TR | TLT | $751.9K | 8,700 | -0.38pp | 2q | +22.5%+$138.3K | |
| SPDR SERIES TRUST | KRE | $748.5K | 10,000 | - | new | NEW | |
| ACADIA PHARMACEUTICALS INC | ACAD | $726.7K | 28,725 | - | new | NEW | |
| WESTERN DIGITAL CORP | WDC | $723.0K | 1,132 | - | new | NEW | |
| SPDR SERIES TRUST | XHB | $693.4K | 6,000 | - | new | NEW | |
| BIONTECH SE | BNTX | $679.4K | 7,301 | -0.40pp | 2q | +6.0%+$38.2K | |
| LEGEND BIOTECH CORP | LEGN | $625.8K | 21,669 | - | new | NEW | |
| SPDR SERIES TRUST | KIE | $609.9K | 10,000 | - | new | NEW | |
| ORUKA THERAPEUTICS INC | ORKA | $601.0K | 6,315 | -0.09pp | 2q | +22.7%+$111.2K | |
| FRANKLIN TEMPLETON ETF TR | FLTW | $591.0K | 5,600 | -0.10pp | 2q | +51.4%+$200.5K | |
| UNITED THERAPEUTICS CORP DEL | UTHR | $560.8K | 1,035 | -0.16pp | 2q | +96.4%+$275.2K | |
| SELECT SECTOR SPDR TR | XLF | $514.7K | 9,600 | -0.16pp | 4q | +54.8%+$182.3K | |
| SELECT SECTOR SPDR TR | XLK | $495.4K | 2,600 | +0.08pp | 4q | +1200.0%+$457.2K | |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | $442.4K | 5,427 | - | new | NEW | |
| MARVELL TECHNOLOGY INC | MRVL | $439.1K | 1,474 | - | new | NEW | |
| ALUMIS INC | ALMS | $433.2K | 15,396 | -0.14pp | 2q | +28.0%+$94.7K | |
| ILLUMINA INC | ILMN | $416.4K | 2,368 | -0.24pp | 2q | -21.7%-$115.7K | |
| PROTAGONIST THERAPEUTICS INC | PTGX | $404.3K | 3,298 | -0.79pp | 2q | -64.7%-$739.9K | |
| ANTERIS TECHNOLOGIES GLOBAL | AVR | $386.4K | 39,233 | - | new | NEW | |
| COGENT BIOSCIENCES INC | COGT | $375.3K | 9,698 | -0.39pp | 4q | -29.6%-$158.1K | |
| HEWLETT PACKARD ENTERPRISE C | HPE | $369.6K | 8,193 | - | new | NEW | |
| CERTARA INC | CERT | $355.8K | 54,326 | - | new | NEW | |
| IMMUNOVANT INC | IMVT | $348.4K | 9,043 | - | new | NEW | |
| MICROCHIP TECHNOLOGY INC. | MCHP | $344.9K | 3,782 | - | new | NEW | |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | $328.2K | 9,829 | - | new | NEW | |
| BIOLIFE SOLUTIONS INC | BLFS | $327.9K | 11,612 | - | new | NEW | |
| ADAPTIVE BIOTECHNOLOGIES COR | ADPT | $324.9K | 15,149 | - | new | NEW | |
| MARAVAI LIFESCIENCES HLDGS I | MRVI | $315.8K | 50,615 | - | new | NEW | |
| CRYOPORT INC | CYRX | $315.1K | 20,067 | - | new | NEW | |
| BELITE BIO INC | BLTE | $309.2K | 2,008 | -0.78pp | 3q | -66.6%-$615.3K | |
| TAIWAN SEMICONDUCTOR MANUFAC | TSM | $305.6K | 640 | - | new | NEW | |
| 10X GENOMICS INC | TXG | $296.2K | 7,725 | - | new | NEW | |
| SYNDAX PHARMACEUTICALS INC | SNDX | $278.8K | 12,755 | - | new | NEW | |
| YUM CHINA HLDGS INC | YUMC | $264.6K | 6,473 | - | new | NEW | |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | $262.6K | 13,489 | - | new | NEW | |
| BIOAGE LABS INC | BIOA | $256.7K | 10,472 | -0.27pp | 2q | -49.6%-$253.0K | |
| ALBERTSONS COMPANIES INC | ACI | $252.9K | 18,689 | - | new | NEW | |
| STRUCTURE THERAPEUTICS INC | GPCR | $249.3K | 4,645 | -0.13pp | 2q | +10.9%+$24.4K | |
| TANGO THERAPEUTICS INC | TNGX | $239.4K | 7,658 | -0.33pp | 2q | -62.6%-$400.3K | |
| ABSCI CORPORATION | ABSI | $228.5K | 19,712 | - | new | NEW | |
| ENLIVEN THERAPEUTICS INC | ELVN | $228.3K | 4,499 | - | new | NEW | |
| CORVUS PHARMACEUTICALS INC | CRVS | $225.8K | 15,112 | - | new | NEW | |
| CAPRICOR THERAPEUTICS INC | CAPR | $225.0K | 9,342 | - | new | NEW | |
| MAZE THERAPEUTICS INC | MAZE | $222.8K | 7,465 | - | new | NEW | |
| CME GROUP INC | CME | $221.5K | 1,003 | - | new | NEW | |
| BLOOM ENERGY CORP | BE | $220.7K | 729 | - | new | NEW | |
| MASTERCARD INCORPORATED | MA | $213.1K | 415 | - | new | NEW | |
| ABCELLERA BIOLOGICS INC | ABCL | $212.7K | 27,092 | - | new | NEW | |
| COSTAR GROUP INC | CSGP | $210.3K | 7,425 | - | new | NEW | |
| OTIS WORLDWIDE CORP | OTIS | $207.9K | 2,903 | - | new | NEW | |
| MINERALYS THERAPEUTICS INC | MLYS | $205.9K | 7,633 | - | new | NEW | |
| CLIMB BIO INC | CLYM | $198.7K | 15,241 | -0.11pp | 2q | -38.0%-$121.9K | |
| SILENCE THERAPEUTICS PLC | SLN | $179.3K | 16,334 | - | new | NEW | |
| TAL ED GROUP | TAL | $155.3K | 16,233 | - | new | NEW | |
| CLEVELAND-CLIFFS INC NEW | CLF | $123.7K | 13,176 | - | new | NEW | |
| LUMEN TECHNOLOGIES INC | LUMN | $91.7K | 11,942 | - | new | NEW | |
| SNAP INC | SNAP | $90.3K | 20,330 | - | new | NEW | |
| NEWELL BRANDS INC | NWL | $89.5K | 14,584 | - | new | NEW | |
| PLUG PWR INC | PLUG | $76.1K | 28,077 | -0.01pp | 2q | +150.5%+$45.7K | |
| SELECT SECTOR SPDR TR | XLI | $74.1K | 400 | -0.46pp | 4q | -87.9%-$537.2K | |
| JETBLUE AIRWAYS CORP | JBLU | $72.9K | 12,725 | - | new | NEW | |
| AMC ENTMT HLDGS INC | AMC | $70.7K | 37,228 | - | new | NEW | |
| KOSMOS ENERGY LTD | KOS | $59.9K | 28,404 | - | new | NEW | |
| CCC INTELLIGENT SOLUTIONS HL | CCC | $56.9K | 11,019 | - | new | NEW | |
| BRANDYWINE RLTY TR | BDN | $52.0K | 16,416 | -0.01pp | 2q | +53.4%+$18.1K | |
| SABLE OFFSHORE CORP | SOC | $50.6K | 16,430 | - | new | NEW | |
| XEROX HOLDINGS CORP | XRX | $41.2K | 13,164 | - | new | NEW | |
| SELECT SECTOR SPDR TR | XLP | $24.9K | 300 | -0.45pp | 2q | -95.2%-$498.4K |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Biotech & Pharma | $65.2M | 14.2% |
| Semiconductors & Electronics | $44.8M | 9.8% |
| Banks & Lending | $32.9M | 7.2% |
| Capital Markets | $31.5M | 6.9% |
| Funds & ETFs | $29.9M | 6.5% |
| Business Services | $28.5M | 6.2% |
| Transport & Logistics | $25.7M | 5.6% |
| Software & IT Services | $16.7M | 3.6% |
| Healthcare Services | $9.1M | 2.0% |
| Insurance | $7.8M | 1.7% |
| Other sectors | $15.1M | 3.3% |
| Not classified | $151.9M | 33.1% |
What the disclosed book did
This is not the fund's return. A 13F shows long US equity positions only, so shorts, bonds, foreign listings, private holdings and cash are all invisible here. What this measures is the quarter's change in value of the positions this manager disclosed, had they been left untouched - the return a reader following the filing would have earned.
| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +22.1% | +14.8% | +7.3% | 84% |
| Q1 2026 | -6.6% | -4.6% | -2.0% | 100% |
| Q4 2025 | +0.3% | +2.4% | -2.1% | 91% |
| Q3 2025 | +8.5% | +7.8% | +0.7% | 77% |
Market is SPY over the same two quarter ends, priced the same way as everything else here - the median across every filer reporting it. It is a large-cap US proxy, so a manager holding small caps or biotech will beat or trail it for reasons that are not skill. Prices are quarter-end to quarter-end and say nothing about the path in between, or about trades opened and closed inside a quarter.
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $459.0M | 128 | 83 | 23 | 20 | 36 | 63.7% | 44 |
| Q1 2026 | $112.5M | 81 | 38 | 22 | 20 | 61 | 59.6% | 44 |
| Q4 2025 | $678.7M | 104 | 71 | 18 | 9 | 44 | 73.8% | 42 |
| Q3 2025 | $100.1M | 77 | 72 | 1 | 3 | 40 | 52.2% | 45 |
| Q2 2025 | $112.6M | 45 | 15 | 7 | 12 | 381 | 73.6% | 44 |
| Q1 2025 | $843.2M | 411 | 239 | 67 | 68 | 128 | 22.4% | 43 |
| Q4 2024 | $487.4M | 300 | 0 | 0 | 0 | 0 | 32.9% | 49 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.